Effects of caloric restriction combined with moderate or vigorous intensity exercise on metabolic control and inflammation
| ISRCTN | ISRCTN86152135 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN86152135 |
| Secondary identifying numbers | N/A |
- Submission date
- 04/10/2013
- Registration date
- 19/11/2013
- Last edited
- 17/01/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Background and study aims
People who do not do much physical activity or who have excess body fat have an increased risk of diseases such as type 2 diabetes and cardiovascular disease. Physical activity alone or in combination with caloric restriction (a calorie restricted diet) offer huge benefits in terms of weight loss and metabolic control. The purpose of the study is to investigate whether vigorous-intensity exercise offers additional health benefits compared to energy-matched moderate-intensity exercise in combination with caloric restriction.
Who can participate?
Males and postmenopausal women, aged 45-64 years who are overweight/obese and inactive (no participation in regular structured exercise and less than 30 minutes of moderate-intensity exercise on most days of the week), non-smokers, not taking any drugs that may interfere with the study and whose weight has been stable for the last 6 months.
What does the study involve?
Participants were asked to complete a range of preliminary tests (e.g., body mass, maximum oxygen uptake, body composition, habitual physical activity) after which they completed a 3-week intervention.
Participants were randomly allocated to either a moderate (MOD) or a vigorous (VIG) physical exercise group. Both groups experienced a fixed energy loss induced by caloric restriction and increased physical activity via either moderate (MOD) or vigorous (VIG) physical exercise.
Before and after the intervention, participants came to the laboratory in the morning after an overnight fast. A cannula (tube) was inserted for repeat blood sampling and a biopsy was taken from the abdominal (stomach) area. Participants then consumed a glucose-based solution and blood samples were taken over the following 2 hours.
What are the possible benefits and risks of participating?
Participants who took part in this study were given a copy of their personalised results and the normal range for these measures: Cardio-respiratory fitness (e.g., how fit you are), diet (e.g., the good and bad aspects of your diet), blood measurements (e.g., cholesterol), blood pressure, percentage body fat, muscle mass, etc.
Participants were on a low energy diet, they therefore might have become hungry on several occasions throughout the study. However, the intervention was designed to result in a safe level of weight loss.
Participants temporarily increased their normal exercise patterns. This might have caused some inconvenience. A small fat sample was taken at the beginning and end of the trial from around the waist. All fat samples were taken by someone who has been specially trained to do so in order to minimise discomfort. Bruising might have occurred for a few days after taking this sample. There is a small chance of localised infection but good practice minimises this risk.
We measured body fat using a very sophisticated and precise technique (dual energy x-ray absorptiometry or DEXA). DEXA is a non-invasive technique that uses a very low exposure to radiation. The radiation dose is often compared to the small exposure experienced during a short flight. This technique is routinely used in hospitals but at the same time this does represent some exposure to a small amount of radiation. The risks associated with this amount of radiation are described as 'trivial' (less than 1 in ten million per whole body scan).
Where is the study run from?
University of Bath (UK)
When is the study starting and how long is it expected to run for?
The study started in January 2009 and completed in June 2011.
Who is funding the study?
University of Bath (UK).
Who is the main contact?
1. Professor Dylan Thompson (scientific)
d.thompson@bath.ac.uk
2. Dr Jean-Philippe Walhin (scientific)
j.walhin@bath.ac.uk
Contact information
Scientific
University of Bath
Claverton Down
Department for Health
Bath
BA2 7AY
United Kingdom
 ORCID ID |
0000-0002-6312-1518 |
|---|---|
| Phone | +44 1225 38 3177 |
| d.thompson@bath.ac.uk |
Scientific
Department for Health
University of Bath
Bath
BA2 7AY
United Kingdom
| ORCID ID |
0000-0002-8103-5541 |
|---|---|
| Phone | +44 1225 386478 |
| j.walhin@bath.ac.uk |
Study information
| Study design | Randomised parallel group study |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Other |
| Study type | Quality of life |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | Effects of caloric restriction combined with moderate or vigorous intensity short-term (three weeks) exercise training on metabolic control and inflammation in middle-aged, overweight and inactive men and postmenopausal women |
| Study objectives | Can vigorous-intensity exercise alongside caloric restriction further improve metabolic control and chronic inflammation in inactive and overweight/obese men and postmenopausal women over the course of a three-week intervention relative to moderate-intensity exercise? |
| Ethics approval(s) | NHS Bath Research Ethics Committee, 05/11/2008, ref: 08/H0101/194 |
| Health condition(s) or problem(s) studied | Obesity, type 2 diabetes, cardiovascular disease |
| Intervention | Participants were asked to complete a range of preliminary tests (e.g., body mass, maximum oxygen uptake, body composition, habitual physical activity) after which they completed a 3-week intervention. Participants were randomly allocated to one of two groups for the intervention. Both groups experienced a fixed energy deficit of 29330 kJ.week-1, induced by caloric restriction and increased physical activity via either moderate (MOD) or vigorous (VIG) physical exercise. Volunteers in both groups were asked to reduce their caloric intake by under-consuming their habitual diet in order to create a caloric deficit of 20950 kJ.week-1. In addition, participants in the MOD group increased their physical activity by walking on a treadmill five times per week at 50% of their maximum oxygen uptake while participants in the VIG group increased their physical activity by walking on a treadmill five times per week at 70% of their maximum oxygen uptake. Importantly, both groups expended 8380 kJ.week-1 (1676 kJ per session for both groups) above rest through increased physical activity. Both groups achieved the same energy deficit over the course of the intervention. Before and after the intervention, participants came to the laboratory in the morning after an overnight fast. A cannula was inserted for repeat blood sampling and an adipose tissue biopsy was taken from the abdominal area. Participants then consumed a glucose-based solution and blood samples were taken over the following 2 hours. |
| Intervention type | Other |
| Primary outcome measure | Changes in insulin sensitivity and glycaemic control. Measured at baseline and at the end of the intervention (i.e., after 21 days). |
| Secondary outcome measures | 1. Other blood measures related to metabolic function and inflammation (e.g., cholesterol, non-esterified fatty acids [NEFA], triacylglycerol, alanine aminotransferase [ALT], interleukin (IL)-6, leptin, adiponectin) 2. Changes in adipose tissue gene expression related to metabolic function and inflammation were measured using real-time quantitative polymerase chain reaction (qPCR). Measured at baseline and at the end of the intervention (i.e., after 21 days). |
| Overall study start date | 01/06/2008 |
| Completion date | 30/06/2012 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 38 |
| Key inclusion criteria | 1. Male and postmenopausal women, aged 45 to 64 2. Overweight/obese (body mass index [BMI] >25 kg.m-2) 3. Physically inactive (no participation in regular structured exercise and they did not do >30 minutes of moderate-intensity exercise on most days of the week) 4. Weight stable (over the past 6 months) |
| Key exclusion criteria | 1. Smoker 2. Age outside range (<45 and >64 years) 3. Positive responses to Physical Activity Readiness Questionnaire 4. Taking medication that may interfere with study 5. Doctor diagnosed condition that might interact with study measures (e.g. cardiovascular disease) |
| Date of first enrolment | 01/01/2009 |
| Date of final enrolment | 30/06/2011 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Bath
BA2 7AY
United Kingdom
Sponsor information
University/education
Claverton Down
Bath
BA2 7AY
England
United Kingdom
| Phone | +44 1225 386478 |
|---|---|
| jpw23@bath.ac.uk | |
| Website | http://www.bath.ac.uk/ |
"ROR" |
https://ror.org/002h8g185 |
Funders
Funder type
University/education
Private sector organisation / Universities (academic only)
- Alternative name(s)
- UniofBath
- Location
- United Kingdom
Results and Publications
| Intention to publish date | 31/12/2016 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Stored in repository |
| Publication and dissemination plan | Planned publication in Physiological Reports. |
| IPD sharing plan | The datasets generated during the current study are stored in the University of Bath's publically available repository via https://doi.org/10.15125/BATH-00313 |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/12/2016 | 17/01/2019 | Yes | No |
Editorial Notes
17/01/2019: Publication reference added
02/11/2016: Jean-Philippe Wlhin has been added as a study contact and a link to the IPD has been added.
16/09/2016: The overall trial dates have been updated from 01/01/2009 - 30/06/2011 to 01/06/2008 - 30/06/2012
09/09/2016: No publications found in PubMed, verifying study status with principal investigator.
